fragmin 18,000units/0.72ml solution for injection pre-filled syringes
pfizer ltd - dalteparin sodium - solution for injection - 25000unit/1ml
fragmin 7,500units/0.3ml solution for injection pre-filled syringes
pfizer ltd - dalteparin sodium - solution for injection - 25000unit/1ml
fragmin 25000 iuml
pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 5000 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism.unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.
fragmin 2500 i.u 0.2 ml
pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.
fragmin 2500 i.uml
pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu/ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections. cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.
fragmin graduated syringe 10,000units/1ml solution for injection pre-filled syringes
pfizer ltd - dalteparin sodium - solution for injection - 10000unit/1ml
fragmin 10,000units/1ml solution for injection ampoules
pfizer ltd - dalteparin sodium - solution for injection - 10000unit/1ml
fragmin 10,000units/4ml solution for injection ampoules
pfizer ltd - dalteparin sodium - solution for injection - 2500unit/1ml
fragmin 100,000units/4ml solution for injection vials
pfizer ltd - dalteparin sodium - solution for injection - 25000unit/1ml
alteparin 2500 iu/0.2 ml solution for injection (sc)
endure medical, inc.; distributor: endure medical, inc. - dalteparin sodium (drug product for emergency use only) - solution for injection (sc) - 2500 iu/0.2 ml